Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling Rett syndrome

Frontiers in Behavioral Neuroscience

Volumn 9, Issue APR, 2015, Pages

  De Filippis, Bianca ^a   Chiodi, Valentina ^a   Adriani, Walter ^a   Lacivita, Enza ^b   Mallozzi, Cinzia ^a   Leopoldo, Marcello ^b   Domenici, Maria Rosaria ^a   Fuso, Andrea ^c,d   Laviola, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Cognition; Intellectual disability; Neurodevelopmental disorders; Rho GTPases; Serotonin; Synaptic plasticity; Transgenic mice

Indexed keywords

LP 211; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN S6; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; S6 KINASE; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BARNES MAZE TEST; COGNITION; CONTROLLED STUDY; DOWEL TEST; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; EXPERIMENTAL BEHAVIORAL TEST; FEMALE; HEALTH STATUS; LONG TERM POTENTIATION; MEMORY DISORDER; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD TEST; PHARMACOLOGICAL STIMULATION; PHENOTYPIC VARIATION; PROTEIN INDUCTION; PROTEIN TARGETING; REFERENCE MEMORY; RETT SYNDROME; STIMULUS RESPONSE; TREATMENT DURATION;

EID: 84936955136     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnbeh.2015.00086     Document Type: Article

References (63)

1. Abdala, A. P., Bissonnette, J. M., and Newman-Tancredi, A. (2014). Pinpointing brainstem mechanisms responsible for autonomic dysfunction in Rett syndrome: therapeutic perspectives for 5-HT1A agonists. Front. Physiol. 5:205. doi: 10.3389/fphys.2014.00205
2. Abdala, A. P., Dutschmann, M., Bissonnette, J. M., and Paton, J. F. (2010). Correction of respiratory disorders in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U S A 107, 18208-18213. doi: 10.1073/pnas.1012104107
3. Adriani, W., Leo, D., Greco, D., Rea, M., di Porzio, U., Laviola, G., et al. (2006). Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression.Neuropsychopharmacology 31, 1946-1956. doi: 10.1038/sj.npp.1300962
4. Adriani, W., Travaglini, D., Lacivita, E., Saso, L., Leopoldo, M., and Laviola, G. (2012). Modulatory effects of two novel agonists for serotonin receptor 7 on emotion, motivation and circadian rhythm profiles in mice.Neuropharmacology 62, 833-842. doi: 10.1016/j.neuropharm.2011.09.012
5. Altabella, L., Sbriccoli, M., Zoratto, F., Poleggi, A., Vinci, R., Lacivita, E., et al. (2014). Differential responses to acute administration of a new 5-HT7-R agonist as a function of adolescent pre-treatment: phMRI and immuno-histochemical study. Front. Behav. Neurosci. 8:427. doi: 10.3389/fnbeh.2014.00427
6. Amir, R. E., van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., and Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188. doi: 10.1038/13810
7. Anderson, W. W., and Collingridge, G. L. (2007). Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. J. Neurosci. Methods 162, 346-356. doi: 10.1016/j.jneumeth.2006.12.018
8. Barnes, C. A. (1979). Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74-104. doi: 10.1037/h0077579
9. Barnes, N. M., and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083-1152. doi: 10.1016/s0028-3908(99)00010-6
10. Beaudet, G., Bouet, V., Jozet-Alves, C., Schumann-Bard, P., Dauphin, F., Paizanis, E., et al. (2015). Spatial memory deficit across aging: current insights of the role of 5-HT7 receptors. Front. Behav. Neurosci. 8:448. doi: 10.3389/fnbeh.2014.00448
11. Canese, R., Zoratto, F., Altabella, L., Porcari, P., Mercurio, L., de Pasquale, F., et al. (2015). Persistent modification of forebrain networks and metabolism in rats following adolescent exposure to a 5-HT7 receptor agonist.Psychopharmacology (Berl) 232, 75-89. doi: 10.1007/s00213-014-3639-6
12. Cerri, C., Fabbri, A., Vannini, E., Spolidoro, M., Costa, M., Maffei, L., et al. (2011). Activation of Rho GTPases triggers structural remodeling and functional plasticity in the adult rat visual cortex. J. Neurosci. 31, 15163-15172. doi: 10.1523/JNEUROSCI.2617-11.2011
13. Chahrour, M., and Zoghbi, H. Y. (2007). The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422-437. doi: 10.1016/j.neuron.2007.10.001
14. Costa, L., Spatuzza, M., D'Antoni, S., Bonaccorso, C. M., Trovato, C., Musumeci, S. A., et al. (2012). Activation of 5-HT7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and Fmr1 knockout mice, a model of Fragile X syndrome. Biol. Psychiatry 72, 924-933. doi: 10.1016/j.biopsych.2012.06.008
15. De Filippis, B., Fabbri, A., Simone, D., Canese, R., Ricceri, L., Malchiodi-Albedi, F., et al. (2012). Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome. Neuropsychopharmacology 37, 1152-1163. doi: 10.1038/npp.2011.301
16. De Filippis, B., Nativio, P., Fabbri, A., Ricceri, L., Adriani, W., Lacivita, E., et al. (2014a). Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for Rett syndrome.Neuropsychopharmacology 39, 2506-2518. doi: 10.1038/npp.2014.105
17. De Filippis, B., Ricceri, L., Fuso, A., and Laviola, G. (2013). Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome. Neuropharmacology 68, 174-183. doi: 10.1016/j.neuropharm.2012.05.048
18. De Filippis, B., Ricceri, L., and Laviola, G. (2010). Early postnatal behavioral changes in the Mecp2-308 truncation mouse model of Rett syndrome. Genes Brain Behav. 9, 213-223. doi: 10.1111/j.1601-183x.2009.00551.x
19. De Filippis, B., Romano, E., and Laviola, G. (2014b). Aberrant Rho GTPases signaling and cognitive dysfunction: in vivo evidence for a compelling molecular relationship. Neurosci. Biobehav. Rev. 46, 285-301. doi: 10.1016/j.neubiorev.2014.06.007
20. Diana, G., Valentini, G., Travaglione, S., Falzano, L., Pieri, M., Zona, C., et al. (2007). Enhancement of learning and memory after activation of cerebral Rho GTPases. Proc. Natl. Acad. Sci. U S A 104, 636-641. doi: 10.1073/pnas.0610059104
21. Díaz de León-Guerrero, S., Pedraza-Alva, G., and Pérez-Martinez, L. (2011). In sickness and in health: the role of methyl-CpG binding protein 2 in the central nervous system. Eur. J. Neurosci. 33, 1563-1574. doi: 10.1111/j.1460-9568.2011.07658.x
22. Di Pilato, P., Niso, M., Adriani, W., Romano, E., Travaglini, D., Berardi, F., et al. (2014). Selective agonists for serotonin 7 (5-HT7) receptor and their applications in preclinical models: an overview. Rev. Neurosci. 25, 401-415. doi: 10.1515/revneuro-2014-0009
23. Domenici, M. R., Azad, S. C., Marsicano, G., Schierloh, A., Wotjak, C. T., Dodt, H. U., et al. (2006). Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 26, 5794-5799. doi: 10.1523/jneurosci.0372-06.2006
24. Etienne-Manneville, S., and Hall, A. (2002). Rho GTPases in cell biology. Nature 420, 629-635. doi: 10.1038/nature01148
25. Garg, S. K., Lioy, D. T., Cheval, H., McGann, J. C., Bissonnette, J. M., Murtha, M. J., et al. (2013). Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome. J. Neurosci. 33, 13612-13620. doi: 10.1523/JNEUROSCI.1854-13.2013
26. Gasbarri, A., and Pompili, A. (2014). Serotonergic 5-HT7 receptors and cognition. Rev. Neurosci. 25, 311-323. doi: 10.1515/revneuro-2013-0066
27. Guseva, D., Wirth, A., and Ponimaskin, E. (2014). Cellular mechanisms of the 5-HT7 receptor-mediated signaling.Front. Behav. Neurosci. 8:306. doi: 10.3389/fnbeh.2014.00306
28. Guy, J., Gan, J., Selfridge, J., Cobb, S., and Bird, A. (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143-1147. doi: 10.1126/science.1138389
29. Hagberg, B. (2002). Clinical manifestations and stages of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8, 61-65. doi: 10.1002/mrdd.10020
30. Hall, A. (2005). Rho GTPases and the control of cell behaviour. Biochem. Soc. Trans. 33, 891-895. doi: 10.1042/bst20050891
31. Hedlund, P. B. (2009). The 5-HT7 receptor and disorders of the nervous system: an overview.Psychopharmacology (Berl) 206, 345-354. doi: 10.1007/s00213-009-1626-0
32. Hedlund, P. B., Leopoldo, M., Caccia, S., Sarkisyan, G., Fracasso, C., Martelli, G., et al. (2010). LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor. Neurosci. Lett. 481, 12-16. doi: 10.1016/j.neulet.2010.06.036
33. Isoda, K., Morimoto, M., Matsui, F., Hasegawa, T., Tozawa, T., Morioka, S., et al. (2010). Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice. Neuroscience 165, 1254-1260. doi: 10.1016/j.neuroscience.2009.11.036
34. Katz, D. M., Berger-Sweeney, J. E., Eubanks, J. H., Justice, M. J., Neul, J. L., Pozzo-Miller, L., et al. (2012). Preclinical research in Rett syndrome: setting the foundation for translational success. Dis. Model. Mech. 5, 733-745. doi: 10.1242/dmm.011007
35. Kobe, F., Guseva, D., Jensen, T. P., Wirth, A., Renner, U., Hess, D., et al. (2012). 5-HT7R/G12 signaling regulates neuronal morphology and function in an age-dependent manner. J. Neurosci. 32, 2915-2930. doi: 10.1523/JNEUROSCI.2765-11.2012
36. Kvachnina, E., Liu, G., Dityatev, A., Renner, U., Dumuis, A., Richter, D. W., et al. (2005). 5-HT7 receptor is coupled to G alpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J. Neurosci. 25, 7821-7830. doi: 10.1523/jneurosci.1790-05.2005
37. Leopoldo, M., Lacivita, E., Berardi, F., Perrone, R., and Hedlund, P. B. (2011). Serotonin 5-HT7 receptor agents: structure-activity relationships and potential therapeutic applications in central nervous system disorders.Pharmacol. Ther. 129, 120-148. doi: 10.1016/j.pharmthera.2010.08.013
38. Leopoldo, M., Lacivita, E., De Giorgio, P., Fracasso, C., Guzzetti, S., Caccia, S., et al. (2008). Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III. J. Med. Chem. 51, 5813-5822. doi: 10.1021/jm800615e
39. Li, Y., Wang, H., Muffat, J., Cheng, A. W., Orlando, D. A., Lovén, J., et al. (2013). Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell. 13, 446-458. doi: 10.1016/j.stem.2013.09.001
40. Loizzo, S., Rimondini, R., Travaglione, S., Fabbri, A., Guidotti, M., Ferri, A., et al. (2013). CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer's disease. PLoS One 8:e65898. doi: 10.1371/journal.pone.0065898
41. Luo, L. (2000). Rho GTPases in neuronal morphogenesis. Nat. Rev. Neurosci. 1, 173-180. doi: 10.1038/35044547
42. Matthys, A., Haegeman, G., Van Craenenbroeck, K., and Vanhoenacker, P. (2011). Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectives. Mol. Neurobiol. 43, 228-253. doi: 10.1007/s12035-011-8175-3
43. Meneses, A. (2014). Memory formation and memory alterations: 5-HT6 and 5-HT7 receptors, novel alternative.Rev. Neurosci. 25, 325-356. doi: 10.1515/revneuro-2014-0001
44. Meneses, A., Perez-Garcia, G., Liy-Salmeron, G., Ponce-López, T., Lacivita, E., and Leopoldo, M. (2015). 5-HT7 receptor activation: procognitive and antiamnesic effects. Psychopharmacology (Berl) 232, 595-603. doi: 10.1007/s00213-014-3693-0
45. Monti, J. M., and Jantos, H. (2014). The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness. Rev. Neurosci. 25, 429-437. doi: 10.1515/revneuro-2014-0016
46. Moretti, P., Levenson, J. M., Battaglia, F., Atkinson, R., Antalffy, B., Amstrong, D., et al. (2006). Learning and memory and synaptic plasticity are impaired in a mouse model of rett syndrome. J. Neurosci. 26, 319-327. doi: 10.1523/jneurosci.2623-05.2006
47. Moroto, M., Nishimura, A., Morimoto, M., Isoda, K., Morita, T., Yoshida, M., et al. (2013). Altered somatosensory barrel cortex refinement in the developing brain of Mecp2-null mice. Brain Res. 1537, 319-326. doi: 10.1016/j.brainres.2013.09.017
48. Percy, A. K., and Lane, J. B. (2005). Rett syndrome: model of neurodevelopmental disorders. J. Child Neurol. 20, 718-721. doi: 10.1177/08830738050200081801
49. Prendergast, B. J., Onishi, K. G., and Zucker, I. (2014). Female mice liberated for inclusion in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 40, 1-5. doi: 10.1016/j.neubiorev.2014.01.001
50. Ramakers, G. J. (2002). Rho proteins, mental retardation and the cellular basis of cognition. Trends Neurosci. 25, 191-199. doi: 10.1016/s0166-2236(00)02118-4
51. Rett, A. (1966). [On a unusual brain atrophy syndrome in hyperammonemia in childhood]. Wien. Med. Wochenschr. 116, 723-726.
52. Ricceri, L., De Filippis, B., and Laviola, G. (2008). Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches. Behav. Pharmacol. 19, 501-517. doi: 10.1097/FBP.0b013e32830c3645
53. Ricceri, L., De Filippis, B., and Laviola, G. (2013). Rett syndrome treatment in mouse models: searching for effective targets and strategies. Neuropharmacology 68, 106-115. doi: 10.1016/j.neuropharm.2012.08.010
54. Ricciardi, S., Boggio, E. M., Grosso, S., Lonetti, G., Forlani, G., Stefanelli, G., et al. (2011). Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum. Mol. Genet. 20, 1182-1196. doi: 10.1093/hmg/ddq563
55. Roberts, A. J., and Hedlund, P. B. (2012). The 5-HT(7) receptor in learning and memory. Hippocampus 22, 762-771. doi: 10.1002/hipo.20938
56. Romano, E., Ruocco, L. A., Nativio, P., Lacivita, E., Ajmone-Cat, M. A., Boatto, G., et al. (2014). Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats. Rev. Neurosci. 25, 383-400. doi: 10.1515/revneuro-2014-0007
57. Samaco, R. C., McGraw, C. M., Ward, C. S., Sun, Y., Neul, J. L., and Zoghbi, H. Y. (2013). Female Mecp2+/- mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies. Hum. Mol. Genet. 22, 96-109. doi: 10.1093/hmg/dds406
58. Santos, M., Summavielle, T., Teixeira-Castro, A., Silva-Fernandes, A., Duarte-Silva, S., Marques, F., et al. (2010). Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 170, 453-467. doi: 10.1016/j.neuroscience.2010.07.010
59. Sarkisyan, G., and Hedlund, P. B. (2009). The 5-HT7 receptor is involved in allocentric spatial memory information processing. Behav. Brain Res. 202, 26-31. doi: 10.1016/j.bbr.2009.03.011
60. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., et al. (2002). Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243-254. doi: 10.1016/s0896-6273(02)00768-7
61. Volpicelli, F., Speranza, L., di Porzio, U., Crispino, M., and Perrone-Capano, C. (2014). The serotonin receptor 7 and the structural plasticity of brain circuits. Front. Behav. Neurosci. 8:318. doi: 10.3389/fnbeh.2014.00318
62. Wilcox, R. G. (ed) (1987). New Statistical Procedures for the Social Sciences. Hillsdale, NJ: Erlbaum.
63. Woods, R., Vallero, R. O., Golub, M. S., Suarez, J. K., Ta, T. A., Yasui, D. H., et al. (2012). Long-lived epigenetic interactions between perinatal PBDE exposure and Mecp2308 mutation. Hum. Mol. Genet. 21, 2399-2411. doi: 10.1093/hmg/dds046